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Abstract
 
Lipoxin A
 
4
 
 (LXA
 
4
 
) is a potent endogenous lipoxygenase-derived eicosanoid with antiinflam-
matory and proresolving properties. Supraphysiological levels of LXA
 
4
 
 are generated during
infection by 
 
Toxoplasma gondii
 
, which in turn reduces interleukin (IL) 12 production by dendritic
cells, thus dampening Th1-type cell-mediated immune responses and host immunopathology.
In the present work, we sought evidence for the structural basis of 
 
T. gondii
 
’s ability to activate
LXA
 
4
 
 biosynthesis. Proteomic analysis of 
 
T. gondii
 
 extract (soluble tachyzoite antigen [STAg]),
which preserves the immunosuppressive and antiinflammatory activity of the parasite, yielded
several peptide matches to known plant lipoxygenases. Hence, we incubated STAg itself with
arachidonic acid and found using LC-UV-MS-MS–based lipidomics that STAg produced both
15-HETE and 5,15-diHETE, indicating that 
 
T. gondii
 
 carries 15-lipoxygenase activity. In addi-
tion, 
 
T. gondii
 
 tachyzoites (the rapidly multiplying and invasive stage of the parasite) generated
LXA
 
4
 
 when provided with arachidonic acid. Local administration of a plant (soybean) lipoxy-
genase itself reduced neutrophilic infiltration in murine peritonitis, demonstrating that 15-
lipoxygenase possesses antiinflammatory properties. Administration of plant 15-lipoxygenase
generated endogenous LXA
 
4
 
 and mimicked the suppression of IL-12 production by splenic
dendritic cells observed after 
 
T. gondii
 
 infection or STAg administration. Together, these results
indicate that 15-lipoxygenase expressed by a pathogen as well as exogenously administered 15-
lipoxygenase can interact with host biosynthetic circuits for endogenous “stop signals” that
divert the host immune response and limit acute inflammation.
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Introduction
 
Arachidonic acid is the substrate for the biosynthesis of a
range of bioactive eicosanoids that include the prostaglandins,
thromboxane, leukotrienes, and lipoxins (1). Lipoxins are
trihydroxy eicosanoids that contain a conjugated tetraene
structure that arises from two sequential lipoxygenase-
catalyzed oxygenations (2). Lipoxins are potent antiinflam-
matory lipid mediators that are formed locally in settings of
heterotypic cell–cell interactions, such as occurring during
inflammation, and are considered endogenous “stop signals”
that limit the accumulation and action of neutrophils, and
are “proresolution” (2) (for review see reference 3). Li-
poxin A
 
4
 
 (LXA
 
4
 
; 5S,6R,15S-trihydroxy-7,9,13-trans-11-cis-
eicosatetraenoic acid) inhibits PMN adherence, migration,
degranulation, and superoxide anion generation, as well as
eosinophil migration and lymphocyte activation (4–6),
and has potent actions on cytokine formation and release
(7). Although endogenous lipoxygenases are recognized
for their importance in lipoxin biosynthesis, the interac-
tion of exogenous lipoxygenases that may be present in
microbes and/or pathogens or other exogenous biological
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Abbreviations used in this paper:
 
 DPBS, Dulbecco’s phosphate buffered saline;
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4
 
, lipoxin A
 
4
 
; STAg, soluble tachyzoite antigen. 
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sources with endogenous lipoxin biosynthesis has not
been investigated.
Along these lines, we recently found that the apicom-
plexan protozoan 
 
Toxoplasma gondii
 
 upon infection in mice
markedly activates LXA
 
4
 
 biosynthesis. Inoculation with 
 
T.
gondii
 
 tachyzoites (the rapidly multiplying and invasive
stage of the parasite) or administration of parasite extracts
(denoted STAg) induces an early splenic dendritic cell acti-
vation, which is characterized by a T cell–independent in-
duction of IL-12 production that involves stimulation of
the chemokine receptor CCR-5 on dendritic cells (8). This
early innate immune response wanes within 1 d and is fol-
lowed by a state of dendritic cell “paralysis,” in which den-
dritic cells lose their ability to generate IL-12 for several
days, and restimulation with 
 
T. gondii
 
 during this period
cannot trigger IL-12 generation (9).
 
T. gondii
 
–induced suppression of dendritic cell function
is mediated, in part, via down-regulation of dendritic cell
CCR5 by the 
 
T. gondii
 
–triggered formation of remarkably
high levels of LXA
 
4
 
 production in vivo (10, 11). An extract
of 
 
T. gondii
 
, STAg, possesses all the biological activity nec-
essary for inducing in vivo dendritic cell paralysis (12). Ap-
parently, specific 
 
T. gondii
 
 components are present in STAg
that are able to dampen dendritic cell IL-12 generation via
dramatic stimulation of LXA
 
4
 
 that, in turn, mediates
CCR5 down-regulation. To identify the principles en-
abling 
 
T. gondii
 
 to specifically activate formation of endog-
enous LXA
 
4
 
, we performed a proteomic analysis of STAg
with the objective of characterizing putative polypeptide
ligands and/or recognition motifs expressed by 
 
T. gondii
 
that might be responsible for the activation of lipoxin bio-
synthesis during infection. Instead, the present experiments
reveal that 
 
T. gondii
 
 itself possesses 15-lipoxygenase activity
that can contribute to the formation of endogenous LXA
 
4
 
derived from host precursors. Moreover, the recognition
that an exogenous 15-lipoxygenase can activate endoge-
nous lipoxin biosynthesis was further supported by the
finding that administration of plant 15-lipoxygenase is bio-
active in an acute inflammatory locus, stimulating LXA
 
4
 
formation and limiting leukocyte recruitment.
 
Materials and Methods
 
Parasites. T.  gondii
 
 tachyzoites (RH88 strain) were cultured
in human fibroblasts using 
 
Mycoplasma
 
-free conditions. The para-
sites were isolated by passage over a glass wool column and
washed twice in cold PBS before being resuspended at 10
 
8
 
 organ-
isms/ml in PBS. A protein-rich aqueous extract, denoted soluble
tachyzoite antigen (STAg), was prepared from sonicated tachy-
zoites as described previously (12). In brief, purified tachyzoites
were pelleted and sonicated (Misonix) with five pulses of 30 s
each. The pellets were resuspended in Dulbecco’s phosphate
buffered saline (DPBS) without divalent cations, pH 7.4, and
centrifuged at 35,000 rpm (100,000 
 
g
 
) for 45 min, and the super-
natant was collected and assayed for its protein content.
 
Proteomic LC-MS-MS Analysis. 
 
A tryptic digest of STAg was
prepared by incubating 50 
 
 
 
g STAg protein with 2.5 
 
 
 
g of mod-
ified sequencing grade trypsin (Promega) in 50 mM ammonium
bicarbonate for 12 h at 27
 
 
 
C. The digest was taken to dryness un-
der reduced pressure by vacuum centrifugation (SpeedVac; Sa-
vant), resuspended in ultrapure water, and stored at 
 
 
 
80
 
 
 
C until
analysis. For LC-MS analysis, the peptides were suspended in
mobile phase A and injected using a Rheodyne 7725i injector
port. The tryptic peptides were separated by liquid chromatogra-
phy on a Jupiter 50 
 
 
 
 2.0 mm reversed phase column at a flow
rate of 200 
 
 
 
l/min delivered by an HPLC pump (SpectraPhysics
P4000; Finnigan MAT). The LC gradient used was: 0–1 min
100% A, 1–35 min 0–60% B, 35–40 min 60–100% B, and 40–45
min 100% B, and the mobile phases were as follows: A, H
 
2
 
O/ace-
tonitrile/formic acid/TFA 95:5:0.1:0.02 (vol/vol/vol); and B,
H
 
2
 
O/acetonitrile/formic acid/TFA 10:90:0.1:0.02 (vol/vol/vol).
A capillary LC system was used as well for some analyses. A
tryptic digest corresponding to 2 
 
 
 
g STAg protein was suspended
in acetonitrile/water/formic acid/TFA 2:98:0.1:0.005 (vol/vol/
vol/vol), loaded onto a Peptide MacroTrap (Michrom Biore-
sources), and placed in the injection loop of a Rheodyne 7725i
injector port just before the column. The adsorbed peptides were
washed with 30 
 
 
 
l of mobile phase A and eluted off the trap onto
the separating column during the LC run. Tryptic peptides were
separated using a reversed phase column (PepMap; ID 300 
 
 
 
m;
length: 15 cm, 3 
 
 
 
m particle size; LC Packings Dionex, equipped
with a thermostat set at 30
 
 
 
C) at a flow rate of 4 
 
 
 
l/min, which
was obtained with a precolumn flow splitter (Accurate; LC Pack-
ings Dionex). The LC gradient used was: 0–70 min 2–60% B,
70–75 min 60–100% B, and 75–80 min 100% B, and the mobile
phases were as follows: A, H
 
2
 
O/acetonitrile/formic acid 95:5:0.1
(vol/vol/vol); and B, H
 
2
 
O/acetonitrile/formic acid 10:90:0.1
(vol/vol/vol).
The mass, charge, and tandem mass spectra of singly and mul-
tiply positively charged peptide ions with a minimum ion inten-
sity of 10
 
4
 
 were determined using dynamic exclusion with a LCQ
Classic electrospray ionization ion trap mass spectrometer, or an
LCQ Advantage electrospray ionization ion trap mass spectrome-
ter (ThermoFinnigan). The mass spectrometers were tuned with
synthetic angiotensin II (Sigma-Aldrich) before running a set of
samples. The column eluate was sprayed from a fused silica capil-
lary (ID 100 
 
 
 
m; OD 190 
 
 
 
m) using sheath and auxiliary nitro-
gen gas. The temperature of the heated capillary was 180
 
 
 
C. Pep-
tide fingerprinting was performed with Sequest (BioWorks
version 2.1) or TurboSequest (BioWorks version 3.1; Ther-
moFinnigan), using the National Center for Biotechnology In-
formation nr.fasta protein database. Tandem MS matching was
performed, taking into account the presence of tryptic cleavage
sites, and possible methionine residue oxidation. Cross-species
peptide mapping was also performed with the consideration that
a tryptic cleavage site would not necessarily have to be present.
The quality of the measured and theoretical tandem mass spectra
matches was inspected.
 
Eicosanoid Lipidomics. 
 
To assess lipoxygenase activity in
STAg, 15 
 
 
 
g STAg total protein extract was added to 0.5 ml
DPBS containing 0.88 mM CaCl
 
2
 
 and 0.49 mM MgCl
 
2
 
, pH 7.4,
with or without 30 
 
 
 
g arachidonic acid (Cayman Chemical). Af-
ter incubating for 30 min at room temperature, two volumes of
ice-cold methanol were added, and samples were stored at
 
 
 
80
 
 
 
C. The samples were extracted using solid phase extraction
(reversed phase Extract Clean/RC; Alltech), as described previ-
ously (10, 13). In brief, the eicosanoids generated by STAg were
identified using liquid chromatography–photodiode array detec-
tor–tandem mass spectrometry (ThermoFinnigan). Reverse-
phase LC was conducted on a Discovery C18 (100 
 
 
 
 2 mm, par-
ticle size 5 
 
 
 
m; Supelco) column at a flow rate of 0.2 ml/min.
The mobile phase consisted of methanol/water/acetic acid (65: 
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35:0.01 vol/vol/vol) with an isocratic elution for 8 min, followed
by a linear gradient to 100% methanol from 8 to 30 min, and iso-
cratic elution at 100% methanol from 30 to 38 min. Tandem
mass spectra were recorded with an electrospray ionization mass
spectrometer (LCQ; ThermoFinnigan). The characteristic parent
ions for the arachidonic acid–derived lipoxygenase products
monoHETE (m/z
 
 
 
  
 
319) and diHETEs (m/z
 
 
 
  
 
335) were
monitored, and tandem mass spectra of these ions were recorded.
Ions of diagnostic value or signature ions for 5-HETE, 12-
HETE, 15-HETE, and 5,15-diHETE were as follows: 5-HETE,
m/z 
 
  
 
319 [M-H], 301, 275, 257, 203, and 119; 12-HETE,
m/z 
 
  
 
319 [M-H], 301, 275, 257, 207, 179, and 163;
15-HETE, m/z
 
 
 
  
 
319 [M-H], 301, 275, 257, 219, and 204;
and 5,15-diHETE, m/z
 
 
 
  
 
335, 317, 299, 291, 273, 253, 235,
and 217 (Fig. 2; compare with reference 10).
 
Analysis of 15-HETE by Enzyme-linked Immunosorbent Assay.
 
For incubations with STAg and inhibitors, 15 
 
 
 
g STAg total
protein extract was added to 0.5 ml DPBS containing 0.88 mM
CaCl
 
2
 
 and 0.49 mM MgCl
 
2
 
, pH 7.4, at 37
 
 
 
C, with a lipoxygen-
ase inhibitor (50 
 
 
 
M ketoconazole; Sigma-Aldrich), 10 
 
 
 
M es-
culetin (Sigma-Aldrich), 10 
 
 
 
M baicalein (Sigma-Aldrich), or 10
 
 
 
M nordihydroguaiaretic acid (BIOMOL Research Laboratories,
Inc.), a cytochrome P
 
450
 
-inhibitor (SKF 525A; 100 
 
 
 
M; BIO-
MOL Research Laboratories, Inc.) and 100 
 
 
 
M 8-methoxypsor-
alen (BIOMOL Research Laboratories, Inc.), or vehicle (0.1%
ethanol; references 14, 15). After 5 min, arachidonic acid was
added to a final concentration of 20 
 
 
 
M. The incubations were
stopped after 30 min by rapid freezing in a dry ice/isopropanol
bath, and samples were stored at 
 
 
 
80
 
 
 
C until analysis. 15-HETE
was measured with a 15S-HETE ELISA (AssayDesigns). Ste-
reospecificity of the 15-HETE 15-carbon alcohol was deter-
mined by coupling 15S-ELISA and LC-MS quantitative analysis;
15-HETE that was formed in identical and simultaneous incuba-
tions of STAg with arachidonic acid was quantitated by LC-MS
analysis, and compared with the amount of 15-HETE measured
by ELISA using standard curves for either 15S-HETE and 15R-
HETE. An additional standard curve for synthetic 15R-HETE
(Cayman Chemical) was made, which displayed 
 
 
 
10% cross-
reactivity compared with 15S-HETE.
 
Tachyzoite Incubations. 
 
Isolated culture-derived tachyzoites
(10
 
7
 
 organisms/well in RPMI 1640 containing 1% BSA) were in-
cubated for 30 min at 37
 
 
 
C in the presence or absence of 20 
 
 
 
M
arachidonic acid (Sigma-Aldrich) and/or 5 
 
 
 
M calcium iono-
phore A23187 (Sigma-Aldrich). The incubations were stopped
by adding 2 ml/well of ice-cold methanol and stored at 
 
 
 
80
 
 
 
C
until assayed. LXA
 
4
 
 was measured by ELISA (Neogen), after
evaporation of the methanol and dilution of samples with ELISA
assay buffer.
 
Native Isoelectric Focusing and In-gel Lipoxygenase Staining.
 
Soybean lipoxygenase 
 
(Glycine max;
 
 Type IV, 360.000 U/mg; 1 U
defined as the amount of enzyme that oxygenates 0.11 nmol lin-
oleic acid/min at 25
 
 
 
C at pH 9.0; Sigma-Aldrich) was suspended
in native rehydration buffer composed of 0.1% Triton X-100
and 0.2% ampholytes (BioLyte pH range 3–10; Bio-Rad Labo-
ratories). Immobilized pH gradient strips (pH range 3–10, 11
cm; Bio-Rad Laboratories) were rehydrated with the lipoxy-
genase-containing native rehydration buffer for 12 h at 10
 
 
 
C.
The protein was focused in a Protean isoelectric focusing unit
(Bio-Rad Laboratories) at 10
 
 
 
C by applying a linear voltage gra-
dient that increased during 1 h to 250 V, for another 2.5 h to
8,000 V, followed by an 112-min focusing period at 8,000 V.
The gel was thereafter placed in a solution containing 
 
o
 
-dianisi-
dine and 90 
 
 
 
g/ml arachidonic acid in 50 mM potassium phos-
phate buffer, pH 7.4. Lipoxygenase activity was visualized with
the development of an orange–brown band within the gel.
Zymosan A–stimulated Peritonitis.  To determine whether 15-
lipoxygenase itself carries antiinflammatory activity, its action was
determined in a murine model of acute neutrophilic inflamma-
tion, zymosan A-stimulated peritonitis (13). All animal studies
were approved by and performed in accordance with guidelines
provided by the Institutional Review Board. Peritonitis was in-
duced in mice (male, FVB, 20–25 g) by intraperitoneal adminis-
tration of 1 mg zymosan A (Sigma-Aldrich) in 1 ml of sterile sa-
line. Soybean lipoxygenase was administered intraperitoneally 5
min before zymosan A. 2 h after zymosan administration, the
mice were killed using isoflurane inhalation, and peritoneal exu-
Figure 1. LC-MS-MS analysis of tryptic peptides from T. gondii protein
extract (STAg). (A) Arrows indicate the position of the following protein
peptide fragments: A, lactate dehydrogenase; B, enolase; C, dense granule
protein 1; D, heat shock protein 70; E, dense granule protein 2; L1, peptide
match to Lycopersicon esculentum lipoxygenase A; and L2, peptide match to
Persea americana lipoxygenase. (inset) Base peak ion trace for peptide L1.
(B) T. gondii proteins identified in STAg.Novel Mechanisms in Antiinflammation 518
date cells were harvested by lavaging the peritoneum with 5 ml
DPBS without calcium and magnesium. Exudate cells were enu-
merated by bright-field microscopy using a Neubauer chamber.
For LXA4 determinations, 6 ml of ice-cold methanol was added
to 3 ml of peritoneal exudate lavage, mixed, and stored at  80 C
until analysis. The samples were extracted using solid phase ex-
traction (as aforementioned) and quantitated using ELISA for
LXA4 (Neogen).
Dendritic Cell Function In Vivo.  For in vivo analysis of den-
dritic cell function, mice (C57Bl/6J) were injected i.p. with ster-
ile DPBS (control), STAg (1  g/mouse), or with several concen-
trations of soybean 15-lipoxygenase (102, 103, 104, or 105
U/mouse) in a total volume of 0.5 ml sterile DPBS. 18 h later,
the animals received a second injection with DPBS, STAg, or
soybean 15-lipoxygenase. 6 h later, spleens were removed and di-
gested with Liberase CI (Roche Biochemicals). Dendritic cells
were semi-purified by dense BSA gradient as described previously
(10, 16). After 12 h incubation in media alone, culture superna-
tants were harvested and assayed for IL-12 p40 levels by ELISA,
as described previously (8, 10).
Results
Proteomic Analysis of T. gondii Protein Extract (STAg).
STAg injection and live T. gondii infection induce LXA4,
5,15-diHETE, and 15-HETE from endogenous sources at
very high levels that appear to be two orders of magnitude
greater than those produced during resolution of inflamma-
tion (10, 17). To address the possibility that specific T. gon-
dii products evoked LXA4 biosynthesis to suppress host de-
fense, we performed a proteomic analysis of a protein
extract of T. gondii (STAg). STAg was digested with
trypsin, tryptic peptides were separated by liquid chroma-
tography (Fig. 1 A), and peptide masses and charges were
determined by mass spectrometry. Using peptide finger-
printing, 11 known T. gondii proteins were identified (Fig.
1 B). Protein coverage ranged from 4.5 (putative transla-
tion initiation factor 5A2) to 44% (lactate dehydrogenase).
Of particular interest, three peptides were found that
matched plant lipoxygenases. These were to tomato li-
poxygenase A and potato lipoxygenase (peptide sequence
QLISSVQSDPANGLQK; L1), avocado lipoxygenase
(LVQSTKFSAPA), and soybean lipoxygenase-3 (MLG-
GLLHRGHKIK) (Fig. 1 B). The quality of the matches
ranged from relatively strong (cross correlation score  
2.00 and 12 out of 32 predicted ions matched) to weak
(cross correlation score   1.07 and 10 out of 20 predicted
ions matched). A base peak ion trace for peptide L1 is shown
in Fig. 1 (inset). Tomato lipoxygenase A and soybean lipoxy-
genase-3 are known to oxygenate polyunsaturated fatty ac-
ids with a positional specificity for a 15- or 12-lipoxygenase
with arachidonic acid as a substrate. These findings suggest
that among several identified T. gondii proteins, a plantlike
lipoxygenase may be present within STAg and carried by
the parasite. T. gondii is known to have incorporated plant-
like genomic components of a possible green algal plastid or-
igin (18, 19). Our proteomic analyses did not indicate the
presence of any of the known human lipoxygenases (or
other human proteins), and, thus, it was unlikely that a li-
poxygenase derived from the host human fibroblast cell line
in which T. gondii is propagated contaminates the STAg
preparation. Along these lines, it is noteworthy that immu-
noblot analysis of STAg lysates did not reveal the presence of
a protein that reacted with polyclonal antibodies directed
against murine leukocyte-type 12-lipoxygenase or rabbit
reticulocyte 15-lipoxygenase (unpublished data).
Figure 2. Lipidomic analysis. Profile of lipoxygenase products formed
by STAg extracts. (A) Selected ion chromatogram for 15-HETE, 12-
HETE, 5-HETE, and 5,15-diHETE formed by 15  g STAg incubated
with 30  g arachidonic acid in 0.5 ml DPBS, pH 7.4, for 30 min (see
Materials and Methods). Tandem mass spectra for the lipoxygenase prod-
ucts 15-HETE (B) and 5,15-diHETE (C). Results are representative of
three independent incubations.Bannenberg et al. 519
Eicosanoid Lipidomics: STAg Converts Arachidonic Acid.
Because the proteomic analysis of STAg suggested that it
contained a lipoxygenase, we tested this directly by assess-
ing enzymatic activity. To determine whether STAg itself
contains lipoxygenase-like enzymatic activity, we incu-
bated STAg with arachidonic acid and assessed the forma-
tion of eicosanoids. After solid-phase extraction, methyl
formate fractions obtained from incubations of STAg with
arachidonic acid showed a pronounced UV absorbance at
234 nm that was indicative of the presence of products
containing conjugated diene chromatophores characteristic
of monohydroxy eicosatetraenoic acids (HETEs; unpub-
lished data). Using LC-UV-MS-MS–based lipidomic anal-
yses, the presence and formation of the main monoHETE
were established, namely 15-HETE, 12-HETE, as well as
the double dioxygenation product 5,15-diHETE (Fig. 2
A). Tandem mass spectra obtained from these isolated
STAg incubations established the identification of 15-
HETE and 5,15-diHETE (Fig. 2 B). The ratio of 15-
HETE/12-HETE formation was  4:1, 1.7:1, and 0.6:1 in
three independent series of analyses. It is noteworthy that
although 5,15-diHETE, the double dioxygenation product
of 15-lipoxygenase (20), was indeed generated, and li-
poxins did not appear to be generated by STAg alone (Fig.
2 A); each of these products were identified in vivo at high
levels after injection of STAg (compare with reference 10).
The formation of 15-HETE from arachidonic acid by
STAg was inhibited by lipoxygenase inhibitors (ketocona-
zole, esculetin, baicalein, and nordihydroguaiaretic acid;
59, 52, 57, and 69% inhibition, respectively), but not by
high concentrations of the cytochrome P450 inhibitors SKF
525A and 8-methoxypsoralen (21 and 7% inhibition, re-
spectively; references 14, 15). A comparison of the amount
of 15-HETE measured by coupling LC-MS analysis to an-
tibody-dependent analysis using standard curves for 15S-
HETE and 15R-HETE (Materials and Methods), indicated
that STAg generated 15-HETE carrying the alcohol group
at carbon-15 in  80% S-configuration.
LXA4 Formation by T. gondii Tachyzoites.  Having es-
tablished that STAg produces 15-HETE, a potential sub-
strate for lipoxin biosynthesis, and 5,15-diHETE, which is
associated with the activation of lipoxin pathways, we next
addressed whether intact T. gondii tachyzoites were capable
of forming LXA4. Tachyzoites were incubated with or
without the substrate arachidonic acid and an agonist, cal-
cium ionophore A23187. T. gondii tachyzoites formed
LXA4 in the presence of added arachidonic acid (Fig. 3).
The formation of LXA4 was further enhanced by simulta-
neous activation of the tachyzoites with calcium iono-
phore. Tachyzoites alone did not form appreciable amounts
of LXA4 in the absence of added arachidonic acid, or with
calcium ionophore alone. These results indicate that intact
T. gondii tachyzoites can generate LXA4, but only when
supplied with exogenous sources of arachidonic acid.
Local Administration of Plant 15-Lipoxygenase Diminishes
Murine Peritonitis.  To determine whether exogenous 15-
lipoxygenase itself carries antiinflammatory properties, we
administered neat soybean lipoxygenase into murine perito-
neum before inducing leukocytic inflammation with zymo-
san A. By native isoelectric focusing and in-gel lipoxygenase
staining, the soybean lipoxygenase preparation used in this
analysis appeared to consist of a single active isoenzyme with
an apparent pI of  6.4 (Fig. 4 A, inset). By SDS-PAGE, fol-
lowed by LC-MS-MS and peptide mapping, this lipoxygen-
ase preparation was shown to be mainly composed of soy-
bean lipoxygenase type-1 (unpublished data). Unexpectedly,
as shown in Fig. 4 A, local administration of soybean 15-
lipoxygenase type-1 gave a marked reduction in inflamma-
tion. Peritoneal exudate cell viability was  95% by trypan
blue staining. Administration of soybean lipoxygenase gave a
dose-dependent increase in exudate LXA4 levels, indicating
that the enzyme remained active in vivo (Fig. 4 B). To-
gether, these results indicate that administration of plant 15-
lipoxygenase promotes local endogenous LXA4 biosynthesis,
and attenuates zymosan A–stimulated murine peritonitis.
Intraperitoneal Administration of Plant 15-Lipoxygenase Mim-
ics STAg-induced Paralysis of Splenic Dendritic Cells.  To de-
termine whether the 15-lipoxygenase activity could account
for the in vivo paralysis of splenic dendritic cells that is
known to occur after T. gondii or STAg administration
(compare with reference 10), we determined IL-12 genera-
tion by splenic dendritic cells from STAg- and/or 15-lipoxy-
genase–treated mice. Administration of 1,000 U of soybean
15-lipoxygenase (i.p.) markedly reduced splenic dendritic
cell IL-12 generation induced by a second challenge with
STAg, namely the dendritic cell paralysis procedure (Fig. 5
A; reference 10). Intraperitoneal administration of the plant
arachidonate 15-lipoxygenase induced a dose-dependent re-
duction in splenic dendritic cell IL-12 production with a na-
Figure 3. LXA4 formation by T. gondii tachyzoites. T. gondii tachyzoites
(107 organisms/well) were incubated for 30 min in the presence or absence of
5  M A23187 and 20  M arachidonic acid. LXA4 was monitored (see
Materials and Methods) and expressed as mean values   SEM (n   3).
Student’s t test; *, P   0.05; **, P   0.005.Novel Mechanisms in Antiinflammation 520
dir at 10.000 U (Fig. 5 B). The shape of the dose–response
curve indicates that a complex relationship exists between
activity and the temporal and spatial distribution of the
immunosuppressive action of exogenously administered 15-
lipoxygenase. Heat inactivation of the soybean 15-lipoxy-
genase (100 C for 60 s) before in vivo administration abol-
ished its impact on IL-12 formation, strongly suggesting that
the catalytic activity of 15-lipoxygenase is required for the
inhibition in vivo of dendritic cell IL-12 generation. We also
observed that local administration of high doses of the lipoxy-
genase (5   105 and 106 U) led to local bleeding and death
of mice. This indicates that adverse actions by lipoxygenase,
namely overdosing, can occur, that may also be responsible
for the observed lack of inhibitory action on dendritic cell
IL-12 formation observed after local administration of 105 U,
giving rise to the V-shaped dose–response (Fig. 5 B). To-
gether, these results indicate that at the lower doses used, 15-
lipoxygenase administered in vivo mimics the suppression of
dendritic cell IL-12 generation that is evoked with T. gondii
infection and STAg administration.
Discussion
We report here using proteomic and lipidomic LC-MS-
MS–based analysis that both microbial lipoxygenase–like ac-
Figure 4. Local administration of plant 15-lipoxygenase diminishes
zymosan A–stimulated leukocyte infiltration, a hallmark of acute inflam-
mation. Peritonitis was induced by intraperitoneal injection of 1 mg
zymosan A. Soybean lipoxygenase (10 or 100   103 U) or vehicle alone
was administered 5 min before zymosan A (1 mg/ml saline i.p.), and after
2 h, peritoneal exudates were collected. (A) Inhibition of peritoneal exudate
cell numbers (mean   SEM; n   5–7; *, significantly different from vehicle;
P   0.05). (inset) In-gel lipoxygenase activity stain with substrate arachi-
donic acid after native isoelectric focusing of soybean 15-lipoxygenase
(LO; 5   103 U). (B) Peritoneal exudate LXA4 levels expressed as mean
values   SEM (n   7–8).
Figure 5. Plant 15-lipoxygenase reduces dendritic cell IL-12 production in
vivo. (A) Intraperitoneal administration of plant 15-lipoxygenase mimics
STAg-induced paralysis of splenic dendritic cells. Mice were injected i.p.
with 1  g STAg, 103 U soybean lipoxygenase, or vehicle alone 18 h before
a second challenge with 1  g STAg, 103 U soybean lipoxygenase, or
vehicle. 6 h later, splenic dendritic cells were harvested and cultured for
another 12 h. Dendritic cell formation of IL-12 p40 was measured (see
Materials and Methods) and expressed as mean values   SEM (n   3).
(B) Dose-dependent induction of dendritic cell paralysis (see Introduction
and references 8–10 and 16 for details) by i.p. administration of plant 15-
lipoxygenase requires catalytic activity. Mice were injected intraperitoneally
with native (closed circles), boiled (open circles) soybean lipoxygenase, or
vehicle alone 18 h before a second challenge with 1  g STAg (i.p.) or
vehicle. 6 h later, splenic dendritic cells were harvested and cultured for
another 12 h. IL-12 p40 was measured (see Materials and Methods) and
expressed as mean values   SEM (n   3).Bannenberg et al. 521
tivity and plant 15-lipoxygenase can, upon infection or ad-
ministration in mice, participate in and enhance endoge-
nous LXA4 biosynthetic circuits. T. gondii tachyzoites carry
a 15-lipoxygenase–like activity (Figs. 1–3) that can initiate
and contribute to parasite-activated biosynthesis of high lev-
els of LXA4 demonstrated earlier during infection that
down-regulates the biosynthesis of splenic dendritic cell IL-
12 formation, that in turn suppresses host immunopathol-
ogy (10). Large scale expressed sequence tag analysis indi-
cates that T. gondii has commandeered several plantlike
genes, probably via secondary endosymbiosis of a green algal
plastid (18, 19). Surprisingly, these key microbial lipoxygen-
ase-mediated actions were also mimicked by local adminis-
tration of a plant 15-lipoxygenase type-1. Together, these
unexpected results illustrate that exogenous lipoxygenases
themselves can activate endogenous lipoxin biosynthetic
pathways and impact the inflammatory status of the host.
In healthy humans, vascular and mucosal LXA4 biosyn-
thesis typically occurs in scenarios of heterotypic cellular in-
teractions, where a lipoxygenase in one cell type catalyzes
the first hydrogen abstraction and oxygenation of arachi-
donic acid to form a monoH(p)ETE, followed by the ac-
tion of a second lipoxygenase and subsequent reactions to
form LXA4 in an interacting or second cell type (for review
see reference 11). For example, PMN 5-lipoxygenase can
convert 15-H(p)ETE generated by a 15-lipoxygenase in
cells present in mucosal surfaces to form LXA4 (11). Within
the vasculature, activated neutrophils generate leukotriene
A4 (LTA4) by 5-lipoxygenase and as much as 50–80% is re-
leased from the cell and rapidly converted by interacting
platelets, for example, to lipoxins by platelet 12-lipoxygen-
ase, or to cysteinyl-leukotrienes by leukotriene C4-synthase
(21–23). Multiple routes for transcellular lipoxin biosynthe-
sis are now known, and 15-, 12-, and 5-lipoxygenase can
each contribute to lipoxin biosynthesis (2, 11). Transcellu-
lar lipoxin biosynthesis occurs and has been studied mainly
in inflammation, during which the formed LXA4 signals the
resolution of the inflammatory state (17, 24). LXA4 can also
be formed in a single cell type, e.g., when PGE2 present in
the inflammatory exudate activates the rapid translation of
15-lipoxygenase message that, together with already present
5-lipoxygenase, establishes a complete lipoxin biosynthetic
circuit within the human neutrophil (17).
In the current studies, we sought to identify the bioac-
tive principle present in the parasite because T. gondii gives
high levels of LXA4 and 5,15-diHETE in vivo (10). Inter-
estingly, we found that T. gondii itself appears to catalyze
the first step in lipoxin biosynthesis.
Support for an active initiation of lipoxin biosynthesis
from within the parasite itself comes from several indepen-
dent sets of findings. First, by proteomic analysis, we iden-
tified several known T. gondii proteins. The analysis was
limited to the number of T. gondii proteins that are de-
scribed and deposited in protein databases (estimated at
 600 proteins at the time of preparation of this paper).
Hence, we sought to identify additional proteins that have
structurally similar homologues in T. gondii by cross-species
peptide matching. We also took into consideration that
measured tryptic peptide masses could match a peptide
from a similar protein present within different species that
did not contain a preceding tryptic cleavage site. Although
tryptic peptides are less well conserved across species, iden-
tification of orthologous proteins by peptide mass via LC-
MS-MS can be performed as the level of peptide conserva-
tion is above that observed by chance (25, 26). Among
several known T. gondii tachyzoite proteins, we were in-
trigued by the finding that several peptides were present
that matched peptide sequences present in plant lipoxygen-
ases. The hypothesis emerged that T. gondii might contain
lipoxygenases that could contribute to LXA4 biosynthesis
observed in vivo (10).
Second, parasite extracts (STAg) tested for eicosanoid
biosynthesis gave results indicating rapid oxygenation of
arachidonic acid with the formation of the reduced alco-
hol-containing products 15-HETE, 12-HETE, and 5,15-
diHETE that were identified by lipidomic analysis. This
product profile points to the presence of an arachidonic
acid 15-lipoxygenase (27, 28). Moreover, the identification
of the double dioxygenation product 5,15-diHETE
strongly supports the presence of an arachidonic acid 15-
lipoxygenase, which is able to both generate 15-H(p)ETE
and use this product again as a substrate that positions in an
inverse orientation in the substrate binding center of the
enzyme to form 5,15-diHETE (20). A marked inhibition of
15-HETE formation by a series of lipoxygenase inhibitors,
but not by cytochrome P450 inhibitors, further supports the
presence of a 15-lipoxygenase enzyme in T. gondii. The 15-
HETE generated by STAg was predominantly in an S-con-
figuration, consistent with reported properties of lipoxy-
genase-based catalysis. Blast searches using the T. gondii
genomic sequence that is currently available have not re-
vealed the genomic origin of this 15-lipoxygenase activity,
and the complete identification of the T. gondii gene awaits
future studies. The peptide matches obtained with STAg
for lipoxygenase point to the existence of a plantlike lipoxy-
genase in T. gondii. T. gondii is an apicomplexan protozoan
that contains several genes with a probable algal plastid ori-
gin (18, 19, 29). Thus, it is possible that a lipoxygenase with
a plant plastid origin could be functional in T. gondii.
Third, we found that intact T. gondii tachyzoites can
form LXA4 in the presence of arachidonic acid. The para-
site 15-lipoxygenase could contribute to part of LXA4 bio-
synthesis in vivo as a result of infection by catalyzing the
first step of lipoxin biosynthesis, a scenario that would re-
quire a host 5-lipoxygenase for conversion of 15-HETE to
LXA4 (Fig. 6). Indeed, 5-lipoxygenase–deficient mice are
incapable of producing LXA4 during T. gondii infection,
and dendritic cell paralysis does not occur (10). The re-
quirement for exogenously supplied arachidonic acid sug-
gests that tachyzoites do depend on host cell arachidonic
acid for the parasite-stimulated LXA4 biosynthesis (Fig. 6).
T. gondii infection of macrophages stimulates 15- and 12-
HETE, the formation of which is dependent on the incor-
poration of live tachyzoites into the host cells (30). T. gon-Novel Mechanisms in Antiinflammation 522
dii tachyzoites may also trigger the release of arachidonic
acid from host phospholipid stores, which is subsequently
used for lipoxin biosynthesis. STAg can induce dendritic
cell paralysis in vivo, but not in isolated dendritic cells in
vitro, indicating that host 5-lipoxygenase activity is likely
to be contained in another cell type in the spleen. Treat-
ment of mice with STAg markedly increases the number of
5-lipoxygenase–containing resident macrophages in the
spleen (10), suggesting that resident macrophages or newly
recruited monocytes can use T. gondii–derived 15-HETE
as a substrate to form LXA4. In addition, a T. gondii lipoxy-
genase could use host 5-lipoxygenase–derived leukotriene
A4 as a substrate to generate LXA4 (22).
A scheme is proposed (Fig. 6) that takes into account
these present observations; namely, hypothetical bidirec-
tional contributions to lipoxin formation by the intracellu-
lar parasite using substrates and intermediates generated by
both the host and parasite lipoxygenases. A similar scenario
may apply to other microbial infections because other para-
sites such as Brugia malayi, Trypanosoma brucei, and Schisto-
soma mansoni have also been shown to generate cyclooxy-
genase- and lipoxygenase-derived eicosanoids that are
generated from host polyunsaturated fatty acids, and that
are essential for parasite development, possibly via modu-
lating the host immune responses and physiology (31–34).
Our findings suggest that T. gondii itself initiates LXA4 for-
mation not by producing an epitope or ligand that activates
lipoxin biosynthesis, but rather by wielding its own 15-
lipoxygenase. Future goals will include nucleotide sequenc-
ing of T. gondii 15-lipoxygenase and related genes.
Administration of lipoxygenase in a model of neutro-
philic infiltration indicated that plant 15-lipoxygenase itself
imparts antiinflammatory activity, and down-regulates
PMN infiltration. Soybean 15-lipoxygenase stimulated the
formation of LXA4, indicating that the enzyme remains ac-
tive in vivo (Fig. 5). Administration of soybean lipoxygen-
ase mimicked the impact of T. gondii infection or STAg ad-
ministration on host dendritic cell formation of IL-12.
These findings indicate that cell-free lipoxygenase can form
an essential part of lipoxin biosynthetic pathways, and func-
tion in vivo to produce LXA4 and initiate endogenous an-
tiinflammation. A lack of leukocyte recruitment to tissues
harboring T. gondii is a typical feature of T. gondii infections
(35). Our results are consistent with this observation be-
cause LXA4 is a potent inhibitor of leukocyte trafficking to
sites of infection (11). T. gondii infection in 5-lipoxygen-
ase–deficient mice leads to an uncontrolled Th1-type im-
mune response and lethality that can be partly controlled
by IL-10, and fully corrected by administration of a LXA4-
stable analogue (36). Our present results indicate that acti-
vation of endogenous lipoxin biosynthetic pathways by ei-
ther T. gondii–initiated biosynthesis or via administration of
exogenous 15-lipoxygenase constitutes a novel means to
stimulate antiinflammation or modify Th1-type host-dam-
aging immune responses that could be used by microbes to
enhance invasion and/or protect the host against excess
parasite-induced IL-12 production.
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